The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The association of tumor infiltrating CD8+ and Foxp3+ cells with overall response rate (ORR) in metastatic renal cell carcinoma (mRCC) patients treated with high-dose aldesleukin (HD IL-2).
 
Jean-Christophe Pignon
No Relationships to Disclose
 
Opeyemi Jegede
No Relationships to Disclose
 
Jesse Novak
No Relationships to Disclose
 
Kathleen Margaret Mahoney
No Relationships to Disclose
 
James Walter Mier
Research Funding - X4 Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Acceleron Pharma (Inst)
 
Gordon J. Freeman
Consulting or Advisory Role - Bethyl Laboratories; Bristol-Myers Squibb; Lilly; Novartis; Novartis (I); Quiet Therapeutics; Roche/Genentech; Seagen; Surface Oncology (I); Xios Therapeutics
Research Funding - Novartis (I); Roche/Genentech (I)
Patents, Royalties, Other Intellectual Property - Amplimmune/Astrazeneca; Boehringer Ingelheim; Bristol-Myers Squibb/Medarex; EMD Serono; Merck; Novartis; Novartis (I); Pfizer (I); Roche/Genentech; Roche/Genentech (I)
 
Michael B. Atkins
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Alkermes; Amgen; Bristol-Myers Squibb; C-Cam; Genentech; Genoptix; GlaxoSmithKline; Infinity Pharmaceuticals; Lilly; Merck; Nektar; Novartis; Pfizer; X4 Pharma
 
Paul J. Catalano
Consulting or Advisory Role - Lilly
 
Sabina Signoretti
Consulting or Advisory Role - AstraZeneca; Merck; Verastem
Research Funding - AstraZeneca (Inst)
Patents, Royalties, Other Intellectual Property - Biogenex
 
David F. McDermott
Consulting or Advisory Role - Alexion Pharmaceuticals; Array BioPharma; Bristol-Myers Squibb; Eisai; exelixis; Genentech/Roche; Merck; Novartis; Pfizer; X4 Pharma
Research Funding - Prometheus (Inst)